seroepidemiolog
virolog
studi
sinc
suggest
human
influenza
pandem
caus
subtyp
influenza
virus
avian
outbreak
hong
kong
china
subtyp
like
candid
next
pandem
howev
unlik
previou
poultri
outbreak
highli
pathogen
avian
influenza
due
control
depopul
without
vaccin
present
circul
genotyp
z
viru
sinc
spread
southern
china
part
world
recent
oseltamivir
vaccin
still
development
stage
phase
clinic
trial
caus
grave
concern
moreov
tobe
pandem
strain
may
littl
cross
immunogen
present
test
vaccin
strain
rel
import
use
airborn
droplet
contact
precaut
infect
control
still
uncertain
laboratoryacquir
avian
influenza
report
laboratori
strain
human
influenza
could
also
caus
anoth
pandem
control
impend
disast
requir
research
addit
nation
intern
prepared
variou
level
epidemiolog
virolog
clinic
featur
laboratori
diagnosi
manag
hospit
infect
control
measur
review
clinic
perspect
chest
protein
hemagglutinin
neuraminidas
major
antigen
determin
influenza
virus
serv
basi
subtyp
classif
hemagglutinin
neuraminidas
type
hemagglutinin
mediat
attach
entri
viru
host
cell
bind
sialic
acid
receptor
cell
surfac
hemagglutinin
also
main
viral
target
protect
humor
immun
neutral
antibodi
bind
affin
hemagglutinin
sialic
acid
residu
partli
account
host
specif
variou
influenza
viru
subtyp
human
virus
preferenti
bind
sialic
acid
link
galactos
linkag
main
type
found
epitheli
cell
human
respiratori
tract
avian
virus
tend
bind
linkag
found
duck
intestin
epithelium
specif
differ
receptor
long
one
explan
speci
barrier
avian
human
influenza
virus
presenc
linkag
pig
tracheal
epithelium
reason
pig
may
serv
mix
vessel
genesi
new
viral
type
coinfect
chicken
may
similar
role
lung
intestin
epithelia
contain
type
linkag
human
respiratori
epithelium
shown
linkag
found
ciliat
noncili
cell
respect
therebi
allow
human
infect
avian
influenza
virus
chang
one
amino
acid
protein
suffici
chang
receptor
bind
specif
virus
thu
barrier
interspeci
infect
overcom
easili
neuraminidas
facilit
spread
virion
host
cleav
glycosid
linkag
sialic
acid
host
cell
surfac
viral
particl
target
neuraminidas
inhibitor
report
mutat
posit
neuraminidas
histidin
tyrosin
isol
vietnames
girl
associ
clinic
laboratori
evid
resist
oseltamivir
zanamivir
ion
channel
crucial
phdepend
dissoci
matrix
protein
nucleocapsid
viral
uncoat
ph
chang
across
transgolgi
network
matur
hemagglutinin
molecul
target
adamantan
amantadin
rimantadin
mutat
serin
asparagin
residu
invari
confer
resist
adamantan
seen
latest
isol
circul
southeast
asia
sinc
late
caus
cellular
apoptosi
act
host
mitochondria
hemagglutinin
protein
appear
import
determin
host
specif
virul
notabl
featur
influenza
virus
propens
undergo
antigen
variat
antigen
drift
antigen
shift
antigen
drift
repres
rel
minor
alter
antigen
hemagglutinin
neuraminidas
mutat
occur
continu
result
select
pressur
host
immun
explain
need
yearli
chang
human
influenza
vaccin
composit
exampl
compon
vaccin
northern
hemispher
season
chang
compar
use
season
antigen
shift
genet
reassort
eight
gene
segment
result
appear
novel
hemagglutininneuraminidas
combin
human
popul
littl
immun
appear
novel
antigen
type
may
lead
pandem
influenza
strain
transmit
effici
human
human
major
pandem
occur
last
centuri
howev
also
possibl
pandem
viru
gener
mere
mutat
avian
influenza
viru
adapt
human
host
without
genet
reassort
waterfowl
natur
reservoir
host
influenza
viru
subtyp
virus
exist
evolutionari
equilibrium
avian
host
bird
remain
asymptomat
despit
infect
shed
larg
number
virion
human
avian
influenza
infect
larg
occur
result
direct
transmiss
virus
infect
bird
human
sporad
case
human
infect
occur
result
direct
animaltohuman
transmiss
laboratori
accid
infect
result
conjunct
tabl
poultri
worker
itali
serolog
evid
infect
avian
influenza
virus
epizoot
worker
conjunct
rest
asymptomat
first
omin
sign
avian
influenza
virus
could
directli
infect
human
avian
speci
larg
scale
occur
hong
kong
result
document
case
six
fatal
decemb
outbreak
infect
occur
among
poultri
south
korea
shortli
afterward
vietnam
japan
thailand
lao
vietnam
cambodia
china
indonesia
malaysia
success
experienc
largestev
poultri
epidem
histori
direct
transmiss
human
occur
three
wave
involv
peopl
death
vietnam
thailand
cambodia
indonesia
china
time
poultri
outbreak
less
virul
avian
influenza
virus
also
occur
taiwan
pakistan
recent
epidem
viru
infect
notabl
two
way
firstli
geograph
extent
epidem
unpreced
tradit
southern
china
consid
epicent
human
highli
pathogen
avian
influenza
virus
circul
highli
pathogen
avian
influenza
virus
among
avian
speci
domest
mammal
farm
worker
document
region
sinc
viru
stretch
border
northward
westward
avian
infect
describ
western
china
mongolia
russia
kazakhstan
inner
mongolia
turkey
romania
put
increasingli
larger
human
popul
risk
infect
secondli
genet
chang
contemporari
virus
chang
ecolog
differ
anim
evid
sinc
waterfowl
hong
kong
start
succumb
infect
also
seen
current
epidem
eurasia
studi
virus
collect
southeast
asia
show
virus
infect
intestin
tract
also
respiratori
tract
duck
higher
viral
load
trachea
cloaca
virus
may
shed
day
infect
duck
contrast
day
older
studi
importantli
demonstr
increas
virul
mammal
shown
anim
studi
natur
infect
cage
felin
endem
area
increas
virul
associ
specif
amino
acid
chang
sequenc
protein
aspart
acid
asparagin
posit
glutam
acid
lysin
posit
dissemin
extrapulmonari
infect
includ
brain
demonstr
mice
ferret
sinc
z
genotyp
virus
emerg
predomin
viru
southern
china
mani
z
genotyp
strain
also
carri
gene
mutat
therebi
confer
resist
adamantan
avian
influenza
virus
also
associ
symptomat
human
infect
recent
year
tabl
human
infect
due
viru
manifest
influenzalik
ill
document
two
patient
hong
kong
infect
occur
two
poultri
worker
canada
largest
outbreak
avian
influenza
infect
human
occur
netherland
virolog
confirm
case
fatal
case
human
acquir
avian
influenza
virus
primarili
direct
contact
mucou
membran
infecti
secret
excreta
infect
bird
contamin
poultri
product
personnel
involv
cull
oper
occasion
infect
main
portal
entri
appear
upper
respiratori
tract
conjunctiva
latter
appear
import
rout
infect
direct
introduct
lower
respiratori
tract
might
occur
follow
massiv
exposur
cull
exercis
although
import
uncertain
role
infect
gi
tract
remain
establish
date
humantohuman
transmiss
avian
influenza
virus
occur
sporad
low
effici
hong
kong
outbreak
one
household
contact
patient
without
histori
exposur
poultri
healthcar
worker
look
patient
subsequ
found
seroposit
recent
southeast
asian
outbreak
possibl
humantohuman
transmiss
suggest
although
two
studi
healthcar
worker
fail
demonstr
transmiss
infect
evid
persontoperson
transmiss
occur
outbreak
netherland
document
infect
develop
three
household
contact
case
two
case
present
conjunct
one
case
present
influenzalik
ill
summari
chang
epidemiolog
pathogen
avian
influenza
virus
set
stage
potenti
particularli
sever
global
epidem
main
clinic
manifest
avian
influenza
infect
depend
viral
subtyp
caus
diseas
infect
mainli
result
conjunct
andor
influenzalik
ill
tabl
outbreak
netherland
case
manifest
conjunct
remain
patient
present
influenzalik
ill
one
veterinarian
influenzalik
ill
day
visit
farm
progress
pneumonia
day
later
pneumonia
persist
despit
treatment
patient
die
ard
day
exposur
hong
kong
outbreak
influenzalik
ill
typic
appear
earli
cours
diseas
conjunct
seen
patient
age
patient
rang
year
mean
year
median
year
patient
age
year
patient
promin
gi
symptom
abdomin
pain
diarrhea
vomit
seven
patient
recov
follow
influenzalik
ill
patient
progress
pneumonia
die
ard
multiorgan
failur
rey
syndrom
pulmonari
hemorrhag
complic
advanc
age
longer
symptomat
period
admiss
pneumonia
leukopenia
lymphopenia
risk
factor
associ
sever
diseas
amantadin
administ
eight
patient
although
clinic
benefit
use
could
confirm
seri
patient
vietnam
infect
diseas
predominantli
affect
younger
popul
mean
age
year
rang
year
among
confirm
case
thailand
mean
age
patient
year
rang
year
histori
contact
poultri
could
found
case
onset
diseas
occur
median
day
exposur
rang
day
main
present
syndrom
communityacquir
pneumonia
fever
univers
present
time
diseas
onset
hospit
rang
day
median
day
import
symptom
diarrhea
present
patient
sever
diarrhea
also
present
symptom
boy
vietnam
whose
sister
die
week
earlier
result
infect
die
dissemin
infect
enceph
lymphopenia
thrombocytopenia
common
find
seri
prognost
indic
ard
death
patient
abnorm
chest
radiograph
find
featur
interstiti
infiltr
lobar
infiltr
collaps
consolid
air
bronchogram
pneumothorax
occur
patient
receiv
mechan
ventil
median
time
appear
ard
day
diseas
onset
thai
seri
rang
day
case
fatal
rate
two
seri
vietnam
thailand
rang
time
onset
death
rang
day
median
day
incid
asymptomat
mild
infect
vs
pneumonia
unknown
postmortem
find
two
patient
hong
kong
die
infect
show
multiorgan
damag
dissemin
intravascular
coagul
lymphoid
tissu
necrosi
atrophi
expect
pulmonari
patholog
diffus
alveolar
damag
hemophagocyt
syndrom
promin
featur
anoth
boy
succumb
infect
thailand
viral
rna
detect
revers
transcriptionpolymeras
chain
reaction
lung
intestin
spleen
activ
viral
replic
limit
lung
intestin
intestin
involv
virus
may
explain
common
occurr
diarrhea
reason
sever
diseas
high
mortal
infect
surpass
previou
pandem
human
influenza
known
presenc
new
viral
subtyp
human
host
prior
immun
total
explain
phenomenon
abil
viru
caus
dissemin
infectioninclud
viremia
encephalitiscould
import
factor
pronounc
activ
proinflammatori
cytokin
cascad
perpetu
inflammatori
respons
could
contribut
tissu
damag
persist
system
inflammatori
respons
syndrom
pathognomon
sign
symptom
infect
clinic
laboratori
radiolog
find
distinguish
caus
influenzalik
ill
sever
commun
acquir
pneumonia
ard
featur
rais
suspicion
avian
influenza
infect
epidemiolog
linkag
endem
area
histori
contact
poultri
frontlin
clinician
therefor
alway
tri
elicit
detail
histori
travel
exposur
anim
suspect
patient
posit
travel
contact
histori
receiv
appropri
radiolog
microbiolog
investig
togeth
proper
infect
control
precaut
patient
mild
influenzalik
ill
may
isol
close
observ
wait
result
laboratori
investig
chest
radiograph
perform
exclud
pulmonari
involv
decis
hospit
base
clinic
assess
diseas
sever
whether
patient
readili
follow
likelihood
avian
influenza
infect
sever
pneumonia
risk
factor
avian
influenza
initi
empir
treat
oseltamivir
addit
broadspectrum
antibiot
eg
plu
macrolid
definit
diagnosi
avian
influenza
posit
viral
cultur
result
clinic
specimen
demonstr
fourfold
rise
serum
neutral
antibodi
titer
toward
present
circul
genotyp
avian
virus
biosafeti
level
laboratori
convalesc
serum
taken
least
day
onset
ill
antibodi
neutral
test
prefer
confirm
baculovirusexpress
recombin
western
blot
test
neither
test
readili
avail
provid
rapid
result
nevertheless
still
order
suspect
case
may
provid
crucial
inform
includ
avail
viral
strain
antivir
suscept
test
epidemiolog
studi
rapid
diagnosi
antigen
detect
revers
transcriptionpolymeras
chain
reaction
influenza
virus
perform
throat
swab
nasopharyng
aspir
put
viral
transport
medium
aerosolgener
procedur
specimen
collect
perform
proper
infect
control
precaut
first
specimen
collect
commenc
antivir
therapi
whenev
possibl
viral
antigen
specimen
may
detect
indirect
immunofluoresc
enzym
immunoassay
rapid
immunochromatograph
assay
unfortun
commerci
avail
test
kit
detect
nucleoprotein
influenza
virus
distinguish
human
avian
influenza
virus
subtyp
sensit
kit
detect
infect
rang
base
small
number
patient
test
specimen
test
posit
influenza
antigen
must
confirm
definit
virolog
studi
confirm
subtyp
viru
revers
transcriptionpolymeras
chain
reaction
appear
promis
test
rapid
detect
avian
influenza
virus
variou
protocol
describ
revers
transcriptionpolymeras
chain
reaction
detect
influenza
virus
specif
gene
test
use
rna
extract
plasma
cerebrospin
fluid
tissu
fece
addit
respiratori
secret
definit
recommend
ideal
revers
transcriptionpolymeras
chain
reaction
primer
combin
choic
laboratori
investig
result
must
confirm
viral
cultur
adamantan
amantadin
rimantadin
neuraminidas
inhibitor
oseltamivir
zanamivir
commonli
use
influenza
treatment
chemoprophylaxi
adamantan
activ
influenza
virus
neuraminidas
inhibitor
activ
influenza
b
virus
adamantan
current
consid
drug
choic
avian
influenza
viru
infect
two
reason
firstli
adamantan
resist
emerg
rapidli
follow
therapeut
use
human
influenza
resist
virus
fulli
transmiss
pathogen
patient
human
influenza
treat
amantadin
may
shed
resist
virus
sometim
earli
day
treatment
adamantaneresist
virus
readili
transmit
contact
secondli
recent
isol
indochina
clade
cambodiathailandvietnam
often
carri
mutat
gene
therebi
render
group
antivir
agent
ineffect
treatment
prevent
emerg
epidem
import
note
chinaindonesia
clade
still
quit
suscept
amantadin
thu
adamantan
still
consid
prophylaxi
commun
contact
pandem
strain
still
suscept
long
shelf
life
amantadin
year
low
cost
make
attract
choic
stockpil
control
clinic
trial
efficaci
neuraminidas
inhibitor
treatment
prophylaxi
human
avian
influenza
infect
perform
given
sever
diseas
clinic
trial
unlik
perform
near
futur
use
neuraminidas
inhibitor
clinic
set
therefor
base
vitro
data
anim
experi
neuraminidas
inhibitor
found
effect
anim
model
prevent
death
improv
surviv
follow
infect
virus
human
influenza
time
commenc
antivir
therapi
directli
relat
surviv
anim
highest
level
protect
seen
neuraminidas
inhibitor
administ
within
h
infect
protect
efficaci
diminish
substanti
neuraminidas
inhibitor
administ
h
infect
howev
length
window
opportun
human
avian
influenza
infect
current
unknown
thai
seri
patient
surviv
oseltamivir
treatment
appear
receiv
agent
earlier
subsequ
die
day
vs
day
diseas
onset
benefit
earli
antivir
intervent
may
nullifi
fact
patient
influenzalik
ill
earli
cours
diseas
often
seek
medic
attent
patient
remot
rural
area
develop
countri
often
delay
access
medic
servic
recent
littl
evid
natur
occur
resist
neuraminidas
inhibitor
isol
highli
suscept
neuraminidas
inhibitor
mean
inhibitori
concentr
ic
usual
nmoll
suscept
avian
influenza
virus
neuraminidas
inhibitor
variabl
appear
relat
specif
neuraminidas
type
tabl
virus
isol
recent
outbreak
readili
inhibit
clinic
achiev
level
neuraminidas
inhibitor
nevertheless
oseltamivirresist
isol
recent
describ
vietnam
report
oseltamivirresist
viru
isol
symptomat
girl
receiv
day
postexposur
oseltamivir
prophylaxi
mg
qd
viru
histidinetotyrosin
substitut
posit
neuraminidas
protein
ic
oseltamivir
found
nmoll
still
within
clinic
achiev
peak
plasma
level
oseltamivir
girl
subsequ
receiv
therapeut
dose
oseltamivir
mg
bid
day
virus
isol
level
resist
appar
lead
treatment
failur
case
although
imposs
draw
definit
conclus
base
singl
case
report
one
viral
clone
girl
isol
howev
ic
oseltamivir
nmoll
extens
use
oseltamivir
treatment
human
influenza
children
shown
associ
substanti
risk
resist
develop
agent
therefor
hardli
surpris
see
oseltamivirresist
virus
number
human
case
increas
use
drug
prophylact
therapeut
purpos
becom
common
strategi
antivir
therapi
prophylaxi
urgent
requir
combin
therapi
oseltamivir
rimantadin
found
synergist
prevent
mortal
infect
anim
studi
although
vitro
anim
studi
avian
influenza
virus
perform
furthermor
higher
virul
recent
isol
virus
appear
reduc
efficaci
neuraminidas
inhibitor
anim
model
fda
us
food
drug
administr
antivir
activ
neuraminidas
inhibitor
denot
ic
valu
determin
either
inhibit
neuraminidas
enzym
activ
plaqu
inhibit
assay
cell
cultur
also
express
ec
latter
test
method
tend
give
variabl
result
higher
ic
level
vivo
suscept
influenza
virus
group
compound
close
relat
result
na
enzym
inhibit
assay
unless
otherwis
state
valu
ic
determin
neuroaminidas
enzym
inhibit
ec
determin
cellculturebas
viru
reduct
microcentr
assay
optim
dose
oseltamivir
avian
influenza
like
requir
higher
dose
current
recommend
dosag
human
influenza
increas
dose
especi
indic
patient
high
viral
load
due
delay
present
sever
diseas
shock
poor
oral
drug
absorpt
result
sever
diarrhea
although
oseltamivir
administ
high
dose
healthi
volunt
supratherapeut
dose
without
signific
advers
reaction
potenti
toxic
associ
highdos
regimen
must
close
monitor
therapeut
trial
use
increas
dosag
neuraminidas
inhibitor
avian
influenza
infect
inde
benefici
major
impact
suppli
agent
pandem
situat
one
option
use
combin
oseltamivir
probenecid
doubl
system
exposur
follow
convent
dosag
oseltamivir
anoth
option
use
combin
therapi
two
neuraminidas
inhibitor
one
neuraminidas
inhibitor
plu
one
adamantan
circul
genotyp
suscept
adamantan
one
neuraminidas
inhibitor
plu
ribavirin
viramidin
becom
avail
synergist
effect
combin
need
studi
urgent
vitro
anim
studi
ribavirin
use
treatment
human
influenza
viru
infect
usual
administ
oral
aerosol
occasion
iv
rout
sever
infect
immunocompromis
host
consist
benefit
observ
clinic
studi
current
ribavirin
consid
drug
choic
influenza
infect
limit
vitro
data
activ
ribavirin
avian
influenza
virus
ribavirin
shown
highli
effect
reduc
mortal
mannanenhanc
mice
model
infect
influenza
b
even
treatment
delay
day
infect
oseltamivir
treatment
longer
effect
combin
oseltamivir
ribavirin
treatment
start
delay
time
increas
efficaci
mice
model
viramidin
carboxamidin
analog
ribavirin
also
demonstr
broadspectrum
antivir
activ
like
ribavirin
antiinfluenza
activ
confirm
limit
vitro
anim
studi
viramidin
current
licens
clinic
use
stockpil
neuraminidas
inhibitor
essenti
compon
global
plan
pandem
influenza
despit
compar
efficaci
neuraminidas
inhibitor
therapi
human
influenza
present
emphasi
nation
pandem
plan
world
health
organ
preferenti
recommend
oseltamivir
probabl
rel
lower
serum
level
zanmavir
lack
treatment
data
infect
human
oseltamivir
administ
oral
zanamivir
deliv
oral
inhal
dri
powder
mode
deliveri
zanamivir
could
problemat
certain
popul
young
old
patient
intub
patient
sever
ill
abl
inhal
powder
properli
oseltamivir
easier
administ
theoret
effect
system
infect
sever
pneumonia
collaps
andor
consolid
lung
could
hinder
penetr
inhal
zanamivir
howev
neuraminidas
inhibitor
need
avail
crossresist
two
neuraminidas
inhibitor
incomplet
exampl
oseltamivirresist
isol
vietnam
describ
remain
fulli
suscept
zanamavir
healthi
reserv
zanamivir
reliev
tension
oseltamivir
suppli
may
also
prove
necessari
oseltamivirresist
virus
becom
preval
futur
zanamavir
consid
prophylaxi
healthcar
worker
take
care
patient
receiv
treatment
oseltamivir
avian
influenza
zanamivir
may
use
prophylaxi
treatment
less
sever
ill
patient
higher
blood
level
drug
may
need
blood
level
zanamivir
almost
time
lower
oseltamivir
howev
oseltamivir
may
reserv
patient
system
infect
sever
pneumonia
requir
higher
blood
level
unfortun
formul
zanamivir
newer
agent
peramivir
commerci
avail
preclin
trial
iv
zanamivir
even
administ
dose
mgd
well
toler
achiev
high
blood
respiratori
secret
level
protect
efficaci
also
demonstr
experiment
human
infect
role
combin
neuraminidas
inhibitor
uncertain
case
combin
group
antivir
howev
low
serum
level
inhal
zanamivir
patient
consolid
lung
may
theoret
promot
emerg
zanamivir
resist
viru
crossresist
oseltamivir
immunomodul
corticosteroid
iv
ig
use
treatment
viral
pneumonia
corticosteroid
use
small
number
patient
pneumonia
hong
kong
vietnam
thailand
often
complic
hyperglycemia
number
patient
receiv
corticosteroid
three
outbreak
three
two
death
seven
six
death
eight
six
death
respect
although
cytokin
storm
incrimin
possibl
pathogen
mechan
pneumonia
current
evid
support
benefici
role
corticosteroid
immunomodul
manag
sever
infect
outbreak
sever
acut
respiratori
syndrom
late
expos
vulner
healthcar
worker
nosocomi
transmiss
infecti
diseas
moreov
hospit
epicent
may
serv
sourc
subsequ
largescal
commun
outbreak
henc
hospit
infect
control
crucial
compon
manag
emerg
infecti
diseas
patient
suspect
confirm
avian
influenza
recommend
contact
droplet
precaut
key
measur
airborn
precaut
also
recommend
high
mortal
abil
human
influenza
virus
transmit
droplet
nuclei
rel
import
rout
transmiss
uncertain
present
find
gi
involv
virus
promin
diarrhea
high
fecal
viral
load
patient
overlook
similar
combin
clinicopatholog
find
sar
outbreak
hong
kong
led
unpreced
outbreak
hous
estat
via
airborn
transmiss
virusladen
aerosol
plume
gener
faulti
sewag
system
besid
hospitalacquir
infect
laboratoryacquir
infect
postmortem
examin
seal
report
strain
believ
origin
laboratori
russia
isol
viru
erron
sent
laboratori
countri
profici
test
program
therefor
faulti
laboratori
precaut
also
sourc
pandem
avian
influenza
virus
readili
inactiv
common
disinfect
present
recommend
use
sodium
hypochlorit
alcohol
disinfect
prevent
measur
control
highli
pathogen
avian
influenza
anim
mammoth
task
recent
address
strict
regul
control
bird
poultri
traffickingb
legal
import
smugglingar
crucial
control
intercontinent
spread
avian
influenza
proper
poultryhandl
practic
person
hygien
handwash
minim
contact
bird
basic
precaut
must
enforc
instanc
use
vaccin
poultri
shown
abl
interrupt
viru
transmiss
field
influenza
vaccin
licens
human
use
present
development
work
ongo
inactiv
vaccin
previous
test
human
subject
found
well
toler
vaccin
immunogen
volunt
develop
neutral
antibodi
anoth
recombin
baculovirusexpress
hemagglutinin
vaccin
also
test
human
subject
immunogen
candid
vaccin
appear
protect
anim
model
includ
vaccin
gener
revers
genet
even
though
vaccin
develop
take
place
import
rememb
pandem
strain
may
signific
antigen
differ
vaccin
develop
happen
new
vaccin
would
develop
signific
time
lag
month
effect
vaccin
commerci
avail
mass
vaccin
absenc
effect
human
vaccin
antivir
chemoprophylaxi
remain
viabl
mean
specif
protect
avian
influenza
oseltamivir
prophylaxi
use
netherland
outbreak
highrisk
individu
personnel
involv
cull
oper
infect
farm
hospit
famili
contact
patient
suffer
pneumonia
person
receiv
oseltamivir
prophylaxi
appear
lower
risk
infect
avian
influenza
vs
infect
rate
receiv
prophylaxi
respect
although
differ
statist
signific
perspect
avian
influenza
may
seem
like
candid
next
influenza
pandem
vaccin
probabl
effect
mean
specif
protect
abil
produc
effect
vaccin
time
limit
role
earli
phase
pandem
indiscrimin
use
neuraminidas
inhibitor
human
influenza
viru
infect
discourag
inevit
promot
emerg
neuraminidas
inhibitorresist
influenza
virus
anoth
potenti
concern
reassort
neuraminidas
inhibitorresist
viru
viru
result
neuraminidas
inhibitorresist
reassort
enhanc
humantohuman
transmiss
studi
need
done
urgent
includ
role
combin
antivir
therapi
treat
sever
infect
abil
prevent
emerg
resist
strain
virus
efficaci
agent
ribavirin
aerosol
system
administr
either
alon
combin
explor
antivir
suscept
test
must
perform
new
epidem
strain
virus
resist
adamantan
unpublish
data
oseltamivir
toxic
newborn
rat
dose
time
higher
recommend
pediatr
dosag
use
oseltamivir
infant
year
old
shown
neurotox
confirm
larger
clinic
trial
effort
avert
minim
impact
impend
pandem
base
sole
therapeut
measur
simpl
commun
infect
control
person
hygien
measur
import
respiratori
infect
shown
sever
acut
respiratori
syndrom
epidem
human
avian
infect
current
limit
close
contact
infect
anim
travel
endem
area
avian
influenza
avoid
close
contact
poultri
wild
bird
could
significantli
reduc
risk
infect
